Zydus Lifesciences has entered into exclusive negotiations to acquire a controlling 85.6 percent stake in France-based Amplitude Surgical SA. The deal, valued at euro 256.8 million (Rs 2446.5 crore), will see Zydus pay euro 6.25 (around Rs 595) for a share of Amplitude. The acquisition will help ZydUS diversify into medtech, leveraging Amplitude’s market presence, R&D, and global distribution network. The transaction is subject to regulatory approvals, including clearance from France’S ministry of economy, and the deal is expected to close in the first half of this year. The company’s surgical implants are gaining ground worldwide, with operations spanning Europe, Brazil, Australia, and South Africa. It also provides value-added innovations to meet the needs of patients, surgeons and healthcare facilities. These include the design and development of knee and hip prostheses, which are implanted in place of damaged or worn-out joints.